Joined
·
1,284 Posts
22% of the market is held by Teva
11% by Mylan
8% by Watson
7% by Novartis
3% by Mallinckrodt
49% other makers
Anyone have any experience with these generics?
Source: Fortune Magazine August 17
11% by Mylan
8% by Watson
7% by Novartis
3% by Mallinckrodt
49% other makers
Anyone have any experience with these generics?
Source: Fortune Magazine August 17